查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1235981

女性健康全球市場規模調查和預測：按應用（絕經後骨質疏鬆症、激素性不孕症、子宮內膜異位症/肌瘤、避孕、更年期、多囊卵巢綜合症）、按年齡、地區分析，2022-2029 年

Global Women's Health Market Size study & Forecast, by Application (Postmenopausal Osteoporosis, Hormonal Infertility, Endometriosis & Uterine Fibroids, Contraceptives, Menopause, Polycystic Ovary Syndrome ), by Age and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格

2021 年全球女性健康市場價值約為 381.1 億美元，預計在 2022-2029 年預測期內將以超過 4.8% 的健康增長率增長。

女性健康是指用於治療影響該人群的各種疾病的程序、藥物和手術輔助工具。 泌尿科、營養學、腫瘤學、生殖醫學、更年期和其他醫學專科均涵蓋在內。 改善女性的總體健康狀況和改善疾病管理是女性健康的兩個主要目標。 許多政府正在加緊努力提高公眾對婦女健康的認識。 世界衛生組織 (WHO) 和美國食品和藥物管理局 (FDA) 等多個組織正在引入新的安全舉措以改善女性健康。 此外，女性慢性病發病率的上升、女性老年人口的增加以及女性健康新產品的不斷推出是推動市場增長的主要因素。

多年來，女性慢性病指標促進了全球女性健康市場的增長。 例如，澳大利亞統計局估計，到 2021 年，將近一半 (49.0%) 的澳大利亞女性將患有一種或多種慢性病，五分之一 (20.7%) 的女性將患有兩種或兩種以上。我認為 據國際癌症研究機構預測，亞太地區將在 2020 年報告 101 萬例乳腺癌病例，到 2025 年將增加到 111 萬例，到 2030 年將增加到 120 萬例。 此外，對公共資助的避孕服務和產品的日益未滿足的需求，以及新興經濟體醫療基礎設施的發展，將為預測期內的市場提供良好的增長前景。 然而，不願避孕將阻礙整個 2022-2029 年預測期內的市場增長。

女性健康全球市場研究中考慮的主要區域是亞太地區、北美、歐洲、拉丁美洲和世界其他地區。 由於品牌產品的主導地位、早期產品批准和商業化、有利的報銷政策以及政府監管支持，北美在收入方面佔據了市場主導地位。 另一方面，預計亞太地區在預測期內將以最高複合年增長率增長。 由於老齡化和目標人口增長等因素，以及政府加大力度提高女性人口的健康意識，預計這將在預測期內為市場帶來有利可圖的增長機會。

近期市場趨勢

  • 2021 年 5 月 - Probi 與 Tervisetehnoloogiate Arenduskeskus 簽署了一項研發協議，以開發基於益生菌乳酸菌株的陰道健康新產品。
  • 2021 年 5 月，合眾集團收購了 Axia Women's Health。 此次收購旨在擴大按需輔助服務，改善患者體驗、結果和參與度，並擴大我們的地理足跡。

全球市場報告範圍

  • 歷史數據：2019-2020-2021
  • 估算基準年：2021 年
  • 預測期：2022-2029
  • 報告範圍：收入預測、公司排名、競爭格局、增長因素、趨勢
  • 按地區劃分：北美、歐洲、亞太地區、拉丁美洲、世界其他地區
  • 定制範圍：免費報告定制（最多 8 個工作小時）。 按國家、地區和部門劃分的範圍的添加和更改。

本研究的目的是弄清近年來各個領域和國家的市場規模，並對未來幾年的市場規模進行預測。 該報告旨在捕捉被調查國家工業的定性和定量方面的情況。

它還提供了關鍵方面的詳細信息，例如決定市場未來增長的驅動因素和挑戰。 此外，它還結合了利益相關者投資的潛在微觀市場機會，以及主要參與者的競爭格局等詳細分析。

內容

第 1 章執行摘要

  • 市場概況
  • 2019-2029 年各細分市場的全球市場估計和預測
    • 2019-2029 年按地區劃分的女性保健市場
    • 女性健康市場，按應用分類，2019-2029
    • 2019-2029 年按年齡劃分的女性保健市場
  • 主要趨勢
  • 調查方法
  • 調查先決條件

第 2 章女性健康全球市場定義和範圍

  • 調查目的
  • 市場定義和範圍
    • 調查範圍
    • 工業發展
  • 本次調查涵蓋的年份
  • 貨幣兌換率

第三章全球女性健康市場動態

  • 女性健康市場影響分析 (2019-2029)
    • 市場驅動力
      • 女性慢性病發病率上升
      • 女性老年人口增加
      • 推出促進女性健康進步的新產品
    • 市場挑戰
      • 我對避孕有抵抗力
    • 市場機會
      • 對公共資助的避孕服務和產品的需求日益增長且未得到滿足
      • 新興經濟體的醫療保健基礎設施增長

第四章全球女性健康市場行業分析

  • 波特 5 力模型
    • 供應商的議價能力
    • 買家的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭公司之間的敵對關係
  • 波特 5 力模型的未來方法 (2019-2029)
  • 害蟲分析
    • 政治
    • 經濟的
    • 社交
    • 技術
  • 最佳投資機會
  • 關鍵成功策略
  • 業內人士的前景
  • 分析師的建議和結論

第 5 章風險評估：COVID-19 的影響

  • 評估 COVID-19 對行業的總體影響
  • COVID-19 之前和 COVID-19 之後的市場情景

第 6 章全球女性健康市場：按應用

  • 市場概況
  • 全球女性健康市場：按應用、按性能 - 潛力分析
  • 女性健康全球市場估計和預測（按應用）2019-2029
  • 女性健康市場，細分分析
    • 絕經後骨質疏鬆症
    • 荷爾蒙不育症
    • 子宮內膜異位症/子宮肌瘤
    • 節育
    • 更年期
    • 多囊卵巢綜合症 (PCOS)

第 7 章全球女性健康市場：按年齡分類

  • 市場概況
  • 全球女性健康市場：按年齡、按表現）- 潛力分析
  • 2019-2029 年全球各年齡段女性健康市場的估計和預測
  • 女性健康市場，細分分析
    • 50 歲以上
    • 其他

第 8 章全球女性健康市場：區域分析

  • 女性健康市場、區域市場概況
  • 北美
    • 美國
      • 按應用分類的估計和預測，2019-2029 年
      • 按年齡估算和預測，2019-2029 年
    • 加拿大
  • 歐洲女性健康市場概況
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 意大利
    • 其他歐洲
  • 亞太地區女性保健品市場概況
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 韓國
    • 其他亞太地區
  • 拉丁美洲女性保健品市場概況
    • 巴西
    • 墨西哥
    • 其他拉丁美洲地區
  • 世界其他地方

第 9 章衝突信息

  • 頂級市場策略
  • 公司簡介
    • Pfizer Inc.
      • 關鍵信息
      • 概覽
      • 財務（僅當數據可用時）
      • 產品概覽
      • 近期趨勢
    • Novartis AG
    • Ferring Pharmaceuticals
    • Apothecus Pharmaceutical
    • Agile Therapeutics Inc.
    • AstraZeneca plc
    • Merck & Co
    • Teva Pharmaceutical Industries
    • LUPIN Limited
    • Eli Lilly and Company

第 10 章研究過程

  • 研究過程
    • 數據挖掘
    • 分析
    • 市場評估
    • 驗證
    • 出版
  • 調查受訪者的特徵
  • 調查先決條件

Global Women's Health Market is valued approximately USD 38.11 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 4.8 % over the forecast period 2022-2029. Women's health refers to the procedures, medications, and surgical aids used to treat the various disorders that affect this population. Urology, nutrition, oncology, reproduction, menopause, and other medical specialties are all covered. Enhancing women's general health and improving illness management are the two main objectives of women's health. The efforts of numerous governments to increase public awareness of women's health are intensifying. Several organizations, such as the World Health Organization (WHO) and the US Food and Drug Administration (FDA), are introducing new safety initiatives to improve women's health. Moreover, rise in incidence of chronic health conditions among women and increasing women geriatric population as well as growing introduction of new products for women's health are key factors driving the market growth.

Over the years the indices of chronic diseases in women are contributing towards the growth of the Global Women's Health Market. For instance- as per Australian Bureau of Statics estimates - as of 2021, Almost half of all females in Australia (49.0%) had one or more chronic conditions, with one in five (20.7%) having two or more. Additionally, as per International Agency for Research on Cancer - In Asia Pacific region around 1.01 million cases of breast cancer reported in 2020, and this number is projected to grow to 1.11 million in 2025, and further 1.20 million in 2030. Also, rising unmet need for publicly funded contraceptive services and products as well as growing healthcare infrastructure in developing economies would create lucrative growth prospectus for the market over the projected period. However, reluctance to Use Contraceptives hinders the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Women's Health Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of branded products and early approval & commercialization of products, favorable reimbursement policies, supportive government regulations in the region. Whereas Asia Pacific is expected to grow with a highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, and increasing number of government initiatives for increasing health awareness among female population in the region would create lucrative growth opportunities for the market over the projected period.

Major market players included in this report are:

  • Pfizer Inc.
  • Novartis AG
  • Ferring Pharmaceuticals
  • Apothecus Pharmaceutical
  • Agile Therapeutics Inc.
  • AstraZeneca plc
  • Merck & Co
  • Teva Pharmaceutical Industries
  • LUPIN Limited
  • Eli Lilly and Company

Recent Developments in the Market:

  • In May 2021 - Probi collaborated with Tervisetehnoloogiate Arenduskeskus and signed a research and development agreement to develop novel products based on probiotic lactobacilli strains for vaginal health.
  • In May 2021, Partners Group acquired Axia Women's Health. This acquisition is aimed at expanding in-demand ancillary services, improving patient experience, outcomes and engagement, and expanding its geographical footprint.

Global Women's Health Market Report Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Application, Age, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Application

    Postmenopausal Osteoporosis

    Hormonal Infertility

    Endometriosis & Uterine Fibroids

    Contraceptives

    Menopause

    Polycystic Ovary Syndrome (PCOS)

By Age

  • 50 Years & above
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Women's Health Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Women's Health Market, by Application, 2019-2029 (USD Billion)
    • 1.2.3. Women's Health Market, by Age, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Women's Health Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Women's Health Market Dynamics

  • 3.1. Women's Health Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rise in incidence of chronic health conditions among women
      • 3.1.1.2. Increasing women geriatric population
      • 3.1.1.3. Growing introduction of new products for women's health
    • 3.1.2. Market Challenges
      • 3.1.2.1. Reluctance to Use Contraceptives
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising unmet need for publicly funded contraceptive services and products.
      • 3.1.3.2. Growing healthcare infrastructure in developing economies

Chapter 4. Global Women's Health Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Women's Health Market, by Application

  • 6.1. Market Snapshot
  • 6.2. Global Women's Health Market by Application, Performance - Potential Analysis
  • 6.3. Global Women's Health Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
  • 6.4. Women's Health Market, Sub Segment Analysis
    • 6.4.1. Postmenopausal Osteoporosis
    • 6.4.2. Hormonal Infertility
    • 6.4.3. Endometriosis & Uterine Fibroids
    • 6.4.4. Contraceptives
    • 6.4.5. Menopause
    • 6.4.6. Polycystic Ovary Syndrome (PCOS)

Chapter 7. Global Women's Health Market, by Age

  • 7.1. Market Snapshot
  • 7.2. Global Women's Health Market by Age, Performance - Potential Analysis
  • 7.3. Global Women's Health Market Estimates & Forecasts by Age 2019-2029 (USD Billion)
  • 7.4. Women's Health Market, Sub Segment Analysis
    • 7.4.1. 50 Years and Above
    • 7.4.2. others

Chapter 8. Global Women's Health Market, Regional Analysis

  • 8.1. Women's Health Market, Regional Market Snapshot
  • 8.2. North America Women's Health Market
    • 8.2.1. U.S. Women's Health Market
      • 8.2.1.1. Application breakdown estimates & forecasts, 2019-2029
      • 8.2.1.2. Age breakdown estimates & forecasts, 2019-2029
    • 8.2.2. Canada Women's Health Market
  • 8.3. Europe Women's Health Market Snapshot
    • 8.3.1. U.K. Women's Health Market
    • 8.3.2. Germany Women's Health Market
    • 8.3.3. France Women's Health Market
    • 8.3.4. Spain Women's Health Market
    • 8.3.5. Italy Women's Health Market
    • 8.3.6. Rest of Europe Women's Health Market
  • 8.4. Asia-Pacific Women's Health Market Snapshot
    • 8.4.1. China Women's Health Market
    • 8.4.2. India Women's Health Market
    • 8.4.3. Japan Women's Health Market
    • 8.4.4. Australia Women's Health Market
    • 8.4.5. South Korea Women's Health Market
    • 8.4.6. Rest of Asia Pacific Women's Health Market
  • 8.5. Latin America Women's Health Market Snapshot
    • 8.5.1. Brazil Women's Health Market
    • 8.5.2. Mexico Women's Health Market
    • 8.5.3. Rest of Latin America Women's Health Market
  • 8.6. Rest of The World Women's Health Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Pfizer Inc.
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Novartis AG
    • 9.2.3. Ferring Pharmaceuticals
    • 9.2.4. Apothecus Pharmaceutical
    • 9.2.5. Agile Therapeutics Inc.
    • 9.2.6. AstraZeneca plc
    • 9.2.7. Merck & Co
    • 9.2.8. Teva Pharmaceutical Industries
    • 9.2.9. LUPIN Limited
    • 9.2.10. Eli Lilly and Company

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Women's Health Market, report scope
  • TABLE 2. Global Women's Health Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Women's Health Market estimates & forecasts by Application 2019-2029 (USD Billion)
  • TABLE 4. Global Women's Health Market estimates & forecasts by Age 2019-2029 (USD Billion)
  • TABLE 5. Global Women's Health Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 6. Global Women's Health Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Women's Health Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Women's Health Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Women's Health Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Women's Health Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Women's Health Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Women's Health Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Women's Health Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Women's Health Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. U.S. Women's Health Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 17. U.S. Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. Canada Women's Health Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 19. Canada Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 20. Canada Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. UK Women's Health Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 22. UK Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 23. UK Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. Germany Women's Health Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 25. Germany Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 26. Germany Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. France Women's Health Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 28. France Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 29. France Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. Italy Women's Health Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 31. Italy Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 32. Italy Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Spain Women's Health Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 34. Spain Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 35. Spain Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. RoE Women's Health Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 37. RoE Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 38. RoE Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. China Women's Health Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 40. China Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 41. China Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. India Women's Health Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 43. India Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 44. India Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. Japan Women's Health Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 46. Japan Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 47. Japan Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. South Korea Women's Health Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 49. South Korea Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 50. South Korea Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. Australia Women's Health Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 52. Australia Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 53. Australia Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. RoAPAC Women's Health Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. Brazil Women's Health Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 58. Brazil Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 59. Brazil Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Mexico Women's Health Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 61. Mexico Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 62. Mexico Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. RoLA Women's Health Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 64. RoLA Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 65. RoLA Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. Row Women's Health Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 67. Row Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 68. Row Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. List of secondary sources, used in the study of global Women's Health Market
  • TABLE 70. List of primary sources, used in the study of global Women's Health Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Women's Health Market, research methodology
  • FIG 2. Global Women's Health Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Women's Health Market, key trends 2021
  • FIG 5. Global Women's Health Market, growth prospects 2022-2029
  • FIG 6. Global Women's Health Market, porters 5 force model
  • FIG 7. Global Women's Health Market, pest analysis
  • FIG 8. Global Women's Health Market, value chain analysis
  • FIG 9. Global Women's Health Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Women's Health Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Women's Health Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Women's Health Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Women's Health Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Women's Health Market, regional snapshot 2019 & 2029
  • FIG 15. North America Women's Health Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Women's Health Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Women's Health Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Women's Health Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Women's Health Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable